Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.

Area of Science:

• Immunology
• Allergy Research
• Cellular Biology

Background:

• Th2 cells are crucial for allergic eosinophil-rich type 2 inflammation.
• A subset of Th2 cells, termed pathogenic effector Th2 (peTh2) cells, exhibits enhanced effector function.
• peTh2 cells differ in gene expression, transcription factor usage, and signaling pathways compared to conventional Th2 cells.

Purpose of the Study:

• To review the characteristics and role of peTh2 cells in allergic eosinophilic inflammation.
• To examine peTh2 cells in both mouse models and human disease.
• To highlight peTh2 cells as a potential therapeutic target for type 2 inflammatory conditions.

Main Methods:

• Review of existing literature on Th2 cell subpopulations.
• Analysis of studies investigating peTh2 cell function in mouse models of allergic inflammation.
• Examination of human studies linking peTh2 cells to allergic diseases.

Main Results:

• peTh2 cells demonstrate superior effector functions compared to conventional Th2 cells.
• These cells are significantly associated with the pathogenesis of allergic eosinophilic inflammation.
• Distinct molecular and signaling profiles differentiate peTh2 cells.

Conclusions:

• peTh2 cells are key drivers of allergic eosinophilic inflammation.
• Targeting peTh2 cells presents a promising therapeutic avenue for type 2 inflammatory diseases.
• Further research into peTh2 cell biology is warranted for effective treatment strategies.